While GHK-Cu is generally well-tolerated in topical research, certain contraindications or precautions should be considered, especially for systemic research or in specific populations: Systemic Research: For systemic applications, GHK-Cu is generally not recommended for subjects who are pregnant, breastfeeding, have active cancer, or suffer from Wilsons disease (a condition involving copper accumulation)
No Clinician Interaction Needed for Many Online GLP-1 Receptor Agonist Prescribers THURSDAY, July 9, 2026 -- Online glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescription vendors frequently do not require clinician interaction, according to a research letter published online July 6 in the Journal of the American Medical Association
Hemachand T, Gopalakrishnan B, Salunke DM et al (2002) Sperm plasma-membrane-associated glutathione S-transferases as gamete recognition molecules
What Sex-Specific Risks Mean for a GLP-1 Treatment Plan Its good to have an awareness of sex-specific risks, but the impact of a GLP-1 is still mostly based on the individual and their specific health conditions
3c and Fig
Sinagra E, Pompei G, Tomasello G, Cappello F, Morreale GC, Amvrosiadis G, et al
